1294-1295 / 1676
Prostate cancer: Problem
•
Prostate cancer
–
1.3 million patients in 5 years
–
Most common cancer for men
–
IMRT one of main treatments
•
Rectal toxicities
–
Incontinence, rectal bleeding
–
Late (3 years after treatment)
•
Dose escalation
–
More than 80 Gy
–
Progression free survival
Zelefsky, M. et al. European Urology (2011)
PSA Relapse Free survival
PSA Relapse Free survival
Months
Months
RT Dose <81 Gy
RT Dose >= 81 Gy
RT Dose <81 Gy
RT Dose >= 81 Gy